Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Deborah Plana, M.D.,Ph.D.

Concepts (70)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiratory Protective Devices22021470.810 Why?
Bibliometrics120223510.630 Why?
Occupational Exposure1202118090.370 Why?
Research Design3202261800.290 Why?
Neoplasms52023220720.290 Why?
Clinical Trials as Topic1202280560.260 Why?
Decontamination12021720.180 Why?
Equipment and Supplies, Hospital12020590.180 Why?
Sterilization120211300.170 Why?
Biomarkers, Pharmacological120201620.170 Why?
Ventilators, Mechanical120212870.160 Why?
Masks120212090.160 Why?
Hydrogen Peroxide120217320.140 Why?
Lymphoma, T-Cell120183050.130 Why?
Antineoplastic Combined Chemotherapy Protocols32023117120.130 Why?
Xenograft Model Antitumor Assays2202035840.120 Why?
Kaplan-Meier Estimate2202265440.110 Why?
Combined Modality Therapy2202385520.110 Why?
National Cancer Institute (U.S.)220242960.100 Why?
Drug Therapy, Combination1202264980.100 Why?
Molecular Targeted Therapy2202028030.090 Why?
Models, Statistical2202250750.090 Why?
Medical Oncology1202223130.090 Why?
Cell Communication1201616530.080 Why?
Head and Neck Neoplasms1202328820.080 Why?
Proportional Hazards Models12022125310.070 Why?
Monocytes1201625750.070 Why?
Pandemics3202186240.070 Why?
Proto-Oncogene Proteins1201844900.070 Why?
Peptide Fragments1201851250.070 Why?
Randomized Controlled Trials as Topic12022103440.060 Why?
Humans1520247606210.060 Why?
Delivery of Health Care1202253250.060 Why?
CD4-Positive T-Lymphocytes1201643530.060 Why?
Ovarian Neoplasms1202048780.050 Why?
Cytokines1201673430.050 Why?
Mitogen-Activated Protein Kinase Kinases120246420.050 Why?
Equipment Reuse12021450.050 Why?
Antineoplastic Agents22020136300.050 Why?
Lung Neoplasms12024132620.040 Why?
Macrocyclic Compounds12018670.040 Why?
Disinfection120212090.040 Why?
Pyridones120247920.040 Why?
Phototherapy120213680.040 Why?
Drug Combinations1202320250.040 Why?
Vincristine1201810390.030 Why?
United States42024724610.030 Why?
Mice, Inbred NOD1201818370.030 Why?
Proto-Oncogene Proteins B-raf1202420530.030 Why?
Prednisone1201815650.030 Why?
Mice, SCID1201826270.030 Why?
Cyclophosphamide1201822210.030 Why?
Coculture Techniques1201613420.030 Why?
Doxorubicin1201822090.020 Why?
Tumor Cells, Cultured1201861310.020 Why?
Patient Selection1202242830.020 Why?
Artificial Intelligence1202325570.020 Why?
Logistic Models12022133140.020 Why?
Hospitals1202039280.020 Why?
Drug Resistance, Neoplasm1202052530.020 Why?
Gene Expression Regulation, Neoplastic1202085150.010 Why?
Retrospective Studies22023803720.010 Why?
Prognosis12023296580.010 Why?
Cells, Cultured12016189570.010 Why?
Mutation12024299320.010 Why?
Treatment Outcome12020650170.010 Why?
Mice12018812080.010 Why?
Female220203912700.010 Why?
Animals120181679630.000 Why?
Male120163597440.000 Why?
Plana's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.